Searched for
ZYDUS LIFE JEFFERIES
Zydus Lifesciences shares zoom 7% after USFDA nod for Dasatinib tabletsZydus Lifesciences share price: Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multi...06 Mar, 2025, 10.03 AM IST- LIC Housing Finance shares jump 2% as board approves Rs 1.23 lakh crore borrowing plan for FY26LIC Housing Finance shares saw a rise after its board approved a significant borrowing plan of Rs 1.23 lakh crore for FY26 through various ...06 Mar, 2025, 09.36 AM IST
- TCS shares in focus after partnership with Vantage Towers for telecom site management platformTCS has partnered with Vantage Towers, Europe’s second-largest telecom tower operator, to launch a digital service platform to enhance prop...06 Mar, 2025, 08.55 AM IST
- Wipro shares in focus after launch of AI-first platform TelcoAI360 to help telecom sector cut costsDeveloped in collaboration with Wipro’s AI partner ecosystem and leveraging ServiceNow’s telecommunications industry solutions suite, Telco...06 Mar, 2025, 08.29 AM IST
- Hot stocks: Brokerage view on Bajaj Auto, KEI Industries, Zydus Life and L&T TechMacquarie rates Bajaj Auto as neutral citing disappointing gross margins, while Jefferies is optimistic on KEI Industries, raising its targ...17 Oct, 2024, 08.58 AM IST
- Jefferies upgrades Zydus Life to 'Buy' on strong US pipeline potential, stock up 4%Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a 'Buy' rating, citing the strength of the company’s US pipeline as a ma...28 Aug, 2024, 01.49 PM IST
- Hot stocks: Brokerage view on L&T Finance, IndiGo and Zydus LifesciencesAxis Capital has downgraded IndiGo from a buy rating to an add rating, though it has raised the target price to Rs 5,100 from Rs 4,700. The...28 Aug, 2024, 09.07 AM IST
- Hot Stocks: Brokerage view on Phoenix Mills, Anupam Rasayan; CLSA downgrades DelhiveryCLSA downgraded Delhivery to underperform, Jefferies raised Zydus Life target, and Anupam Rasayan had balance sheet concerns. Citigroup rec...21 May, 2024, 11.03 AM IST
- Hot Stocks: Brokerage view on Eicher Motors, Wipro and Adani EnterprisesThe global investment bank sees 47%/50% CAGR for Airport/ANIL EBITDA over FY24-FY28. The balance sheet is well-placed to take up the rise i...14 Feb, 2024, 10.37 AM IST
- Hot Stocks: Brokerages on Zydus Life, Hindalco, Anupam Rasayan and Alkem LaboratoriesMacquarie maintained an underperform rating on Zydus Life with a target price of Rs 490. The Q2FY24 results were a mixed bag.04 Dec, 2023, 05.23 PM IST
- Hot Stocks: Brokerage view on Zomato, Star Health, Zydus Life and NykaaMorgan Stanley maintained an overweight rating on Zomato but raised the target price to Rs 125 from Rs 115 earlier.21 Sep, 2023, 11.12 AM IST
- Q3 results impact: Tata Motors, Zomato among over 35 stock upgrades and downgradesA team of analysts from global brokerage firm Jefferies has raised the FY23 earnings estimates for 47% of 147 companies under its coverage ...21 Feb, 2023, 10.15 AM IST
- Sensex & Nifty targets, market prediction, top stock picks from 10 brokerages for your 2023 portfolioTop stock picks: The brokerage is bullish on private banks, insurance, select industrials, consumer discretionary, automobiles and telcos. ...04 Jan, 2023, 09.34 AM IST
- Advent set to buy controlling stake in Bharat SerumKotak PE and OrbiMed together that hold 23% stake in Mumbai-based biopharma company Bharat Serums and Vaccines (BSV) are exiting through th...18 Nov, 2019, 04.59 PM IST
- Advent International emerges sole bidder for Bharat SerumsKotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family.21 Jun, 2019, 07.24 AM IST
- Baxter emerges as frontrunner to buy KKR-backed Gland Pharma for $1.1-1.2 billionHyderabad-headquartered Gland is a leading contract manufacturers of injectables, supplying to pharma majors in India and US like Dr Reddy’...12 May, 2016, 06.49 AM IST
- Gland Pharma promoters put their 60 per cent stake on the blockPromoters of Hyderabad-based speciality injectable drugs maker Gland Pharma have decided to put their controlling stake on the block.20 Aug, 2015, 04.00 AM IST
Load More
